SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001823239-23-000089
Filing Date
2023-11-08
Accepted
2023-11-08 17:28:02
Documents
90
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrvi-20230930.htm   iXBRL 10-Q 1796437
2 EX-31.1 mrvi-q32023form10xqxex311x.htm EX-31.1 8887
3 EX-31.2 mrvi-q32023form10xqxex312x.htm EX-31.2 8818
4 EX-32.1 mrvi-q32023xform10xqxex321.htm EX-32.1 4781
5 EX-32.2 mrvi-q32023xform10xqxex322.htm EX-32.2 4722
  Complete submission text file 0001823239-23-000089.txt   10034836

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrvi-20230930.xsd EX-101.SCH 65565
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrvi-20230930_cal.xml EX-101.CAL 136594
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrvi-20230930_def.xml EX-101.DEF 392452
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrvi-20230930_lab.xml EX-101.LAB 840404
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrvi-20230930_pre.xml EX-101.PRE 594341
84 EXTRACTED XBRL INSTANCE DOCUMENT mrvi-20230930_htm.xml XML 1570549
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39725 | Film No.: 231389358
SIC: 2834 Pharmaceutical Preparations